Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus casei PXN 37 and Improved Quality of Life

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 systematic reviews, all reported beneficial effects of Lactobacillus casei PXN 37 on quality of life, with predominantly moderate effect sizes. However, none of the included studies reported statistically significant findings, and doses, forms, and durations were not consistently described. The evidence base is small and preliminary.

  • Studied populations: Patient populations with colorectal cancer undergoing chemotherapy, neurodegenerative diseases (Alzheimer's, Parkinson's, multiple sclerosis, mild cognitive impairment), and gastrointestinal diseases.

Caveats: Available evidence is overwhelmingly positive (3 of 3 studies beneficial), but the evidence base is small and subject to publication bias. None of the included reviews reported statistically significant findings for quality of life improvements, suggesting the effect may be smaller than the predominant direction indicates. Doses and forms were not specified, and study populations varied widely.

Generated Jul 12, 2026
3 of 3 papers
Back to top